The goal of the present study was to provide novel insights into the pathophysiology of cerebellar alterations induced by AIF deficiency in the Hq mouse model of MD by means of a proteomic approach, which could help to identify new therapeutic targets to prevent neuronal death. This evidence concerns the gene AIFM1 and Menkes disease.